• ES - español
  • EN - English
  • MT - Malti
Parliamentary question - E-003951/2015(ASW)Parliamentary question
E-003951/2015(ASW)
European Parliament

Answer given by Mr Andriukaitis on behalf of the Commission

1.6.2015

Written question

The Commission is aware of the importance and scale of diabetes in Europe and intends to continue supporting Member States in promoting good health and addressing the main risk factors of diabetes.

For example, the Commission supports action to promote healthy nutrition through the High Level Group on Nutrition and Physical Activity[1] and the EU platform for action on diet, physical activity and health[2] and through projects co-financed under the Health Programme[3]. The 2007 Strategy for Europe on Nutrition, Overweight and Obesity-related Health Issues[4] and the 2014 Action Plan on Childhood Obesity[5] are provide frameworks for action in this regard.

In addition, the Commission has co-financed a number of diabetes related projects, e.g. Eubirod, SWEET, and IMAGE[6] through its health programmes. The Joint Action on ‘Chronic Diseases and Promoting Healthy Ageing across the Life Cycle’ includes a work package on the prevention and early diagnosis of diabetes type II. Also under FP7[7], the Commission has funded the research project Preview[8] and it may potentially provide future funding opportunities within the Horizon 2020[9] Societal Challenge 2[10], to continue collaborative research on non-communicable diseases, such as diabetes.

Furthermore, the European Parliament-financed pilot project ‘Developing and implementing successful prevention strategies for type II diabetes’ (2015 — 2017) is addressing childhood obesity and diabetes prevention strategies in children.

As such the Commission intends to continue to address diabetes through existing instruments, approaches and policies.

Legal notice - Privacy policy